Stability and pharmacokinetics of flumazenil in the rat.

作者: Jaap W. Mandema , Josy M. Gubbens-Stibbe , Meindert Danhof

DOI: 10.1007/BF02244294

关键词: AntagonistBioavailabilityOral administrationFlumazenilHalf-lifePharmacologyChemistrySodium fluorideDistribution (pharmacology)Pharmacokinetics

摘要: The pharmacokinetics of flumazenil in the rat were determined after 2.5 mg/kg intravenous and 25 oral administration. Following administration was rapidly eliminated with an extremely short terminal half-life (mean±SE,n=8) 8.3±0.3 min due to a large total blood clearance 147±7 ml/kg/min combined relatively small volume distribution at steady-state 1.33±0.07 l/kg. After absorbed; however, bioavailability low (28±4%) variable. Flumazenil found be unstable vitro disappeared (mean±SE,n=5) 8.3±1 31±4 body room temperature, respectively. samples stabilized by addition sodium fluoride (NaF) cooling 0°C. had stored −35°C when analyzed later times. Presumably esterases are responsible for observed instability. A sensitive HPLC assay measure concentrations is also described.

参考文章(13)
R I Shader, D J Greenblatt, L G Miller, S M Paul, Benzodiazepine receptor occupancy in vivo: correlation with brain concentrations and pharmacodynamic actions. Journal of Pharmacology and Experimental Therapeutics. ,vol. 240, pp. 516- 522 ,(1987)
H. Friedman, DarrellR. Abernethy, DavidJ. Greenblatt, RichardI. Shader, The pharmacokinetics of diazepam and desmethyldiazepam in rat brain and plasma. Psychopharmacology. ,vol. 88, pp. 267- 270 ,(1986) , 10.1007/BF00180822
W. Hunkeler, H. Möhler, L. Pieri, P. Polc, E. P. Bonetti, R. Cumin, R. Schaffner, W. Haefely, Selective antagonists of benzodiazepines. Nature. ,vol. 290, pp. 514- 516 ,(1981) , 10.1038/290514A0
Erico P. Bonetti, Lorenzo Pieri, Rudolf Cumin, Rudolf Schaffner, Margherita Pieri, Elkan R. Gamzu, Rita K. M. M�ller, Willy Haefely, Benzodiazepine antagonist Ro 15-1788: Neurological and behavioral effects Psychopharmacology. ,vol. 78, pp. 8- 18 ,(1982) , 10.1007/BF00470579
Richard G. Lister, David J. Greenblatt, Darrell R. Abernethy, Sandra E. File, Pharmacokinetic studies on Ro 15-1788, a benzodiazepine receptor ligand, in the brain of the rat. Brain Research. ,vol. 290, pp. 183- 186 ,(1984) , 10.1016/0006-8993(84)90752-2
H. Möhler, J. G. Richards, Agonist and antagonist benzodiazepine receptor interaction in vitro Nature. ,vol. 294, pp. 763- 765 ,(1981) , 10.1038/294763A0
Sandra E. File, Sharon Pellow, Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788. Psychopharmacology. ,vol. 88, pp. 1- 11 ,(1986) , 10.1007/BF00310505
P. Polc, J. -P. Laurent, R. Scherschlicht, W. Haefely, Electrophysiological studies on the specific benzodiazepine antagonist Ro 15-1788 Naunyn-Schmiedeberg's Archives of Pharmacology. ,vol. 316, pp. 317- 325 ,(1981) , 10.1007/BF00501364
Rex N. Brogden, Karen L. Goa, Flumazenil Drugs. ,vol. 35, pp. 448- 467 ,(1988) , 10.2165/00003495-198835040-00004
R I Shader, D J Greenblatt, D R Abernethy, R H deJong, B L Ehrenberg, E M Sellers, J D Bonin, H G Giles, R M Arendt, In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution. Journal of Pharmacology and Experimental Therapeutics. ,vol. 227, pp. 98- 106 ,(1983)